Characterization of Monoclonal Antibodies to Measure Cell Surface Protein Levels of Human Interferon-Lambda Receptor 1

Journal article


de Weerd, Nicole A., Ogungbola, Olamide, Liu, Xinyun, Matthews, Antony Y., Ismail, Amina, Vivian, Julian Philip, Lim, San S., Tyrrell, D. Lorne, Putcha, Niru, Skawinski, Mike, Dickensheets, Harold, Lavoie, Thomas B., Donnelly, Raymond P., Hertzog, Paul J. and Santer, Deanna M.. (2023). Characterization of Monoclonal Antibodies to Measure Cell Surface Protein Levels of Human Interferon-Lambda Receptor 1. Journal of Interferon and Cytokine Research. 43(9), pp. 403-413. https://doi.org/10.1089/jir.2023.0040
Authorsde Weerd, Nicole A., Ogungbola, Olamide, Liu, Xinyun, Matthews, Antony Y., Ismail, Amina, Vivian, Julian Philip, Lim, San S., Tyrrell, D. Lorne, Putcha, Niru, Skawinski, Mike, Dickensheets, Harold, Lavoie, Thomas B., Donnelly, Raymond P., Hertzog, Paul J. and Santer, Deanna M.
Abstract

Type III interferons (IFN-lambdas, IFN-λs) are important antiviral cytokines that can also modulate immune responses by acting through a heterodimeric receptor composed of the specific and limited expressed IFN-λR1 chain and the ubiquitous IL-10R2 chain, which is shared with IL-10 family cytokines. Conflicting data have been reported regarding which cells express the IFN-λR1 subunit and directly respond to IFN-λs. This is, in part, owing to transcript levels of the IFN-λR1 gene, IFNLR1, not always correlating with cell surface protein levels. In this study, we tested a panel of novel monoclonal antibodies (mAbs) that specifically recognize human IFN-λR1. Initially, antigen specificity was confirmed by enzyme-linked immunosorbent assay (ELISA), from which a subset of antibodies was selected for additional flow cytometry and neutralization assays. We further characterized two antibodies based on their strong ELISA binding activity (HLR1 and HLR14) and found only HLR14 could reliably detect cell surface IFN-λR1 protein on a variety of cell lines by flow cytometry. HLR14 could also detect IFN-λR1 protein on certain primary human blood cells, including plasmacytoid dendritic cells and B cells from peripheral blood. Availability of the HLR14 mAb will enable the quantification of IFN-λR1 protein levels on cells and better characterization of the cell specificity of the IFN-λ response.

Keywordstype III interferons; flow cytometry; antiviral; IFN receptors
Year01 Jan 2023
JournalJournal of Interferon and Cytokine Research
Journal citation43 (9), pp. 403-413
PublisherMary Ann Liebert Inc
ISSN1079-9907
Digital Object Identifier (DOI)https://doi.org/10.1089/jir.2023.0040
Web address (URL)https://www.liebertpub.com/doi/10.1089/jir.2023.0040
Open accessPublished as non-open access
Research or scholarlyResearch
Page range403-413
Publisher's version
License
All rights reserved
File Access Level
Controlled
Output statusPublished
Publication dates
Online15 Sep 2023
Publication process dates
Completed27 Jul 2023
Deposited12 Mar 2024
Additional information

Copyright 2023, Mary Ann Liebert, Inc., publishers.

Place of publicationUnited States
Permalink -

https://acuresearchbank.acu.edu.au/item/90475/characterization-of-monoclonal-antibodies-to-measure-cell-surface-protein-levels-of-human-interferon-lambda-receptor-1

Restricted files

Publisher's version

  • 13
    total views
  • 0
    total downloads
  • 5
    views this month
  • 0
    downloads this month
These values are for the period from 19th October 2020, when this repository was created.

Export as

Related outputs

Engineering Cell Lines for Specific Human Leukocyte Antigen Presentation
Jin, Dongbin, Loh, Khai Lee, Shamekhi, Tima, Ting, Yi Tian, Lim Kam Sian, Terry C. C., Roest, James, Ooi, Joshua D., Vivian, Julian Philip and Faridi, Pouya. (2023). Engineering Cell Lines for Specific Human Leukocyte Antigen Presentation. In In Jenkins, Brendan J. (Ed.). Inflammation and Cancer : Methods and Protocols pp. 351-369 Springer - Humana Press. https://doi.org/10.1007/978-1-0716-3331-1_25
Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection
Ullah, Tomalika R., Johansen, Matt D., Balka, Katherine R., Ambrose, Rebecca L., Gearing, Linden J., Roest, James, Vivian, Julian Philip, Sapkota, Sunil, Jayasekara, W. Samantha N., Wenholz, Daniel S., Aldilla, Vina R., Zeng, Jun, Miemczyk, Stefan, Nguyen, Duc H. and et. al.. (2023). Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection. Nature Communications. 14(1), pp. 1-13. https://doi.org/10.1038/s41467-023-41381-9
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells
Palmer, William H., Leaton, Laura Ann, Codo, Ana Campos, Crute, Bergren, Roest, James, Zhu, Shiying, Petersen, Jan, Tobin, Richard P., Hume, Patrick S., Stone, Matthew, van Bokhoven, Adrie, Gerich, Mark E., McCarter, Martin D., Zhu, Yuwen, Janssen, William J., Vivian, Julian Philip, Trowsdale, John, Getahun, Andrew, Rossjohn, Jamie, ... Norman, Paul J.. (2023). Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells. Science Immunology. 8(84), pp. 1-18. https://doi.org/10.1126/sciimmunol.ade5343
The allopurinol metabolite, oxypurinol, drives oligoclonal expansions of drug-reactive T cells in resolved hypersensitivity cases and drug-naïve healthy donors
Mifsud, Nicole A., Illing, Patricia T., Ho, Rebecca, Tuomisto, Johanna E., Fettke, Heidi, Mullan, Kerry A., McCluskey, James, Rossjohn, Jamie, Vivian, Julian Philip, Reantragoon, Rangsima and Purcell, Anthony W.. (2023). The allopurinol metabolite, oxypurinol, drives oligoclonal expansions of drug-reactive T cells in resolved hypersensitivity cases and drug-naïve healthy donors. Allergy. 78(11), pp. 2980-2993. https://doi.org/10.1111/all.15814
Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C
Moradi, Shoeib, Stankovic, Sanda, O’Connor, Geraldine M., Pymm, Phillip, MacLachlan, Bruce J., Faoro, Camilla, Retière, Christelle, Sullivan, Lucy C., Saunders, Philippa M., Widjaja, Jacqueline, Cox-Livingstone, Shea, Rossjohn, Jamie, Brooks, Andrew G. and Vivian, Julian P.. (2021). Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C. Nature Communications. 12(1), p. Article 2173. https://doi.org/10.1038/s41467-021-22359-x
Growth hormone stops excessive inflammation after partial hepatectomy, allowing liver regeneration and survival through induction of H2-Bl/HLA-G
Ishikawa, Mayumi, Brooks, Andrew J., Fernández-Rojo, Manuel A., Medina, Johan, Chhabra, Yash, Minami, Shiro, Tunny, Kathryn A., Parton, Robert G., Vivian, Julian Philip, Rossjohn, Jamie, Chikani, Viral, Ramm, Grant A., Ho, Ken K.Y. and Waters, Michael J.. (2021). Growth hormone stops excessive inflammation after partial hepatectomy, allowing liver regeneration and survival through induction of H2-Bl/HLA-G. Hepatology. 73(2), pp. 759-775. https://doi.org/10.1002/hep.31297
The role of the HLA Class I α2 Helix in determining ligand hierarchy for the killer cell Ig-like Receptor 3DL1
Saunders, Philippa M., MacLachlan, Bruce J., Widjaja, Jacqueline, Wong, Shu Cheng, Oates, Clare V. L., Rossjohn, Jamie, Vivian, Julian P. and Brooks, Andrew G.. (2021). The role of the HLA Class I α2 Helix in determining ligand hierarchy for the killer cell Ig-like Receptor 3DL1. Journal of Immunology. 206(4), pp. 849-860. https://doi.org/10.4049/jimmunol.2001109
Carbamazepine induces focused T cell responses in resolved Stevens-Johnson syndrome and toxic epidermal necrolysis cases but does not perturb the immunopeptidome for T cell recognition
Mifsud, Nicole A., Illing, Patricia T., Lai, Jeffrey W., Fettke, Heidi, Hensen, Luca, Huang, Ziyi, Rossjohn, Jamie, Vivian, Julian Philip, Kwan, Patrick and Purcell, Anthony W.. (2021). Carbamazepine induces focused T cell responses in resolved Stevens-Johnson syndrome and toxic epidermal necrolysis cases but does not perturb the immunopeptidome for T cell recognition. Frontiers in Immunology. 12, p. Article 653710. https://doi.org/10.3389/fimmu.2021.653710
Structural integrity with functional plasticity : What type I IFN receptor polymorphisms reveal
de Weerd, Nicole A., Vivian, Julian P., Lim, San S., Huang, Stephanie U-Shane and Hertzog, Paul J.. (2020). Structural integrity with functional plasticity : What type I IFN receptor polymorphisms reveal. Journal of Leukocyte Biology. 108(3), pp. 909-924. https://doi.org/10.1002/JLB.2MR0420-152R
The molecular basis of how buried human leukocyte antigen polymorphism modulates natural killer cell function
Saunders, Philippa M., MacLachlan, Bruce J., Pymm, Phillip, Illing, Patricia T., Deng, Yuanchen, Wong, Shu Cheng, Oates, Clare V. L., Purcell, Anthony W., Rossjohn, Jamie, Vivian, Julian P. and Brooks, Andrew G.. (2020). The molecular basis of how buried human leukocyte antigen polymorphism modulates natural killer cell function. Proceedings of the National Academy of Sciences of the United States of America. 117(21), pp. 11636-11647. https://doi.org/10.1073/pnas.1920570117
Downregulation of MHC class I expression by influenza A and B viruses
Koutsakos, Marios, McWilliam, Hamish E.G., Aktepe, Turgut E., Fritzlar, Svenja, Illing, Patricia T., Mifsud, Nicole A., Purcell, Anthony W., Rockman, Steve, Reading, Patrick C., Vivian, Julian P., Rossjohn, Jamie, Brooks, Andrew G., Mackenzie, Jason M., Mintern, Justine D., Villadangos, Jose A., Nguyen, Thi H. O. and Kedzierska, Katherine. (2019). Downregulation of MHC class I expression by influenza A and B viruses. Frontiers in Immunology. 10, p. Article 1158. https://doi.org/10.3389/fimmu.2019.01158
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1
Martin, Maureen P., Naranbhai, Vivek, Shea, Patrick R., Qi, Ying, Ramsuran, Veron, Vince, Nicolas, Gao, Xiaojiang, Thomas, Rasmi, Brumme, Zabrina L., Carlson, Jonathan M., Wolinsky, Steven M., Goedert, James J., Walker, Bruce D., Segal, Florencia P., Deeks, Steven G., Haas, David W., Migueles, Stephen A., Connors, Mark, Michael, Nelson, ... Carrington, Mary. (2018). Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. Journal of Clinical Investigation. 128(5), pp. 1903-1912. https://doi.org/10.1172/JCI98463
HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome
Illing, Patricia T., Pymm, Phillip, Croft, Nathan P., Hilton, Hugo G., Jojic, Vladimir, Han, Alex S., Mendoza, Juan L., Mifsud, Nicole A., Dudek, Nadine L., McCluskey, James, Parham, Peter, Rossjohn, Jamie, Vivian, Julian P. and Purcell, Anthony W.. (2018). HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome. Nature Communications. 9(1), p. Article 4693. https://doi.org/10.1038/s41467-018-07109-w
A subset of HLA-I peptides are not genomically templated : Evidence for cis- and trans-spliced peptide ligands
Faridi, Pouya, Li, Chen, Ramarathinam, Sri H., Vivian, Julian P., Illing, Patricia T., Mifsud, Nicole A., Ayala, Rochelle, Song, Jiangning, Gearing, Linden J., Hertzog, Paul J., Ternette, Nicola, Rossjohn, Jamie, Croft, Nathan P. and Purcell, Anthony W.. (2018). A subset of HLA-I peptides are not genomically templated : Evidence for cis- and trans-spliced peptide ligands. Science Immunology. 3(28), p. Article eaar3947. https://doi.org/10.1126/sciimmunol.aar3947